ANNOUNCEMENT
On 14/07/2009, Tuesday and at 17:00 p.m., the A’ Repeated General Shareholders’ Meeting of “GR. SARANTIS S.A.” took place at the company’s registered offices. During the General Meeting, shareholders representing 18,535,029 shares were present, corresponding to a 51.25% of the company’s share capital (excluding the company’s treasury shares according to L.2190/1920). As a result, the company had the required by the law quorum and majority to make decisions on the daily agenda issues regarding the addition in the company’s objective and consequent adjustment of the article 3 the Company’s Articles of Association and the amendment of the stock option plan.
Specifically, the above Meeting:
- Approved, with 18,506,746 positive votes (i.e. 99.85% of the present votes), the addition in the company’s objective of the following activity: “Production and trade of medicines and food supplements even from third parties or on the behalf of third parties, the representation of licensed distributors of medicine and food supplements, imports and exports of medicines and food supplements” and decided the consequent amendment of Article 3 of the Company’s Articles of Association.
- Approved, with 14,633,279 positive votes (i.e. 78.95% of the present votes), the amendment of the stock option plan and in particular, the General Meeting decided that up to nineteen option series will be issued according to the current plan, while the maximum amount of options that can be issued by the Board of Directors is 3,000,000 (three million). Moreover, the General Meeting decided to amend the “Option Series” definition by adding three new series and amend the exercise price of the sixteenth series.
ANNOUNCEMENT OF THE Α' REPEATED GENERAL SHAREHOLDERS’ MEETING RESOLUTIONS
(93.9KB)
Contact
SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com
Connect with us
We're always looking to connect with those who share an interest.
Stay Tuned
Sign up to receive our latest news update!
Sarantis Group © 2024. All rights reserved.
Terms Of Use
| Privacy Policy
| Cookies Policy
Website Design & Development by
